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SI Materials and Methods
Isolation of Bone Marrow Cell Subsets and FACS. Hematopoietic
stem and progenitor cells (HSPCs) were isolated from C57BL6
bone marrow by ﬁrst depleting lineage-positive cells using speciﬁc
biotinylated antibodies (Table S2), magnetic beads, and a MACS
column (Miltenyi). Viable (7-amino-actinomycin D [7-AAD] neg-
ative) lineage-negative (lin−) cells were next stained with ﬂuo-
rophore-conjugated antibodies (Table S2) and separated using
a FACS Aria (BD) into cKit−, cKit+Sca1−, and lin− cKit+Sca1+
(LKS) subpopulations. Hematopoietic stem cells were further pu-
riﬁed from among the LKS population by sorting out endothelial
protein C receptor (EPCR)+ or CD150+CD48− LKS cells.
CD11b+ and B220+ cells were fractionated from total bone mar-
row (BM) using a MACS column. RBC-depleted PBMCs were
stained with the indicated antibodies (Table S2), washed, and an-
alyzed using a FACSCalibur (BD).
Microarray Analysis. For the microarray, total RNA was collected
from equal numbers of LKS cells and total RBC-depleted BM
using the miRNeasy kit (Qiagen) and subsequently used for a low-
input microarray with Agilent mouse microRNA (miRNA) 10.1
chips (Asuragen). Data represent miRNA-expression levels in
LKS and total bone marrow taken from 10 mice and pooled
before RNA puriﬁcation. Two biological replicates were analyzed
in this way, and both identiﬁed the 11 miRNAs described in
this study.
Quantitative PCR.ABI Taqman was used to quantitate microRNA
levels in different BM cell populations using gene-speciﬁc primers
according to the manufacturer’s instructions.
Competitive Bone-Marrow Reconstitutions.C57BL6 mice expressing
the congenic WBC markers CD45.1 or CD45.2 were used as
bone-marrow donors, and CD45.2 mice were used as recipients.
Equal numbers of HSPC-enriched bone-marrow cells from each
group (obtained from mice treated with 5-ﬂuorouracil for 5 d)
were infected with an miRNA-expressing (CD45.1 cells) or control
vector (CD45.2 cells), and a 1:1 cell mixture was injected i.v. into
lethally irradiated mice.
Retroviral and Lentiviral Vectors. miRNA-expression vectors for-
matted with miR-155 loop and arms were constructed as de-
scribed previously (1) (Table S3). Endogenous miR-125b-1 and
miR-125b-2 sequences were PCR cloned into MG and MGP
retrovectors (1, 2) or a third-generation replication-deﬁcient
lentiviral vector with an elongation factor 1 α (EF1α) promoter.
Retroviral transduction of mouse HSPCs and bone-marrow trans-
plantation were performed as previously described (1, 2). K562
cells were cultured in complete RPMI and infected with retro-
vectors in the presence of polybrene (10 μg/mL). Lentiviral
transduction of CD34+ cells was achieved using an multiplicity of
infection (MOI) of 4 or 40, Retronectin-coated plates (Fisher
Scientiﬁc), and StemSpan serum-free medium (Stem Cell Tech-
nologies). Transduced CD34+ cells were washed and injected
24 h after infection.
Human Immune System Mouse Model. Human immune system
(HIS) mice were generated by injecting 2 × 105 lentivirus trans-
duced CD34+ CB cells intrahepatically into irradiated newborn
Rag2−/−γc−/−mice on a BALB/c genetic background as described
(3). Human hematopoietic cell engraftment was assessed by col-
lecting blood and subjecting peripheral blood mononuclear cells
(PBMCs) to FACS (Table S2).
Histopathology and Complete Blood Cell Counts. These procedures
were performed as described (1, 2).
Statistics.For statistical analysis, a Student two-tailed t test was used.
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Fig. S1. A more extensive cellular fractionation scheme was used to further assess the expression proﬁles of the 11 miRNAs enriched in LKS cells.
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Fig. S2. Each respective miRNA-expressing vector was transfected into 293T cells, and miRNA levels were assessed by Quantitative PCR (qPCR) and normalized
to RNU48.
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Fig. S3. Competitive BM reconstitutions were performed using C57BL6 mice to assess the engraftment potential of BM expressing each of the 11 HSC miRNAs
(CD45.1 cells) compared with control BM (CD45.2 cells). A representative FACS plot of PBMCs from each mouse group stained with CD45.1 is shown (n = 4 at
4 mo postreconstitution). GFP was used to identify cells containing a vector.
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Fig. S4. Wright-stained BM smears and H&E-stained spleen sections from MG and MG-125b(f)–expressing mice 2 mo after reconstitution (Upper Left) or the
same tissues and liver from miR-125b1–expressing mice 2.5 mo postreconstitution (Upper Right and Lower Left). Wright-stained blood smears from MG- and
MG-125b1–expressing mice 3.5 mo after bone-marrow reconstitution (Lower Right). Data represent at least two independent experiments. (Scale bar: spleen
and liver, 200 mm; blood and bone marrow, 40 mm.)
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